| Primary |
| Product Used For Unknown Indication |
32.7% |
| Vitamin D Deficiency |
16.4% |
| Vitamin D Decreased |
12.7% |
| Osteoporosis |
5.5% |
| Depression |
3.6% |
| Hip Fracture |
3.6% |
| Radical Neck Dissection |
3.6% |
| Thyroidectomy |
3.6% |
| Anxiety |
1.8% |
| Bipolar Disorder |
1.8% |
| Diabetes Mellitus |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Hypoparathyroidism |
1.8% |
| Nutritional Supplement |
1.8% |
| Pain |
1.8% |
| Rickets |
1.8% |
| Supplementation Therapy |
1.8% |
| Vitamin Supplementation |
1.8% |
|
| Hypersensitivity |
14.8% |
| Urticaria |
11.1% |
| Nephrolithiasis |
7.4% |
| Unevaluable Event |
7.4% |
| Abdominal Distension |
3.7% |
| Adverse Drug Reaction |
3.7% |
| Amnesia |
3.7% |
| Anaphylactic Shock |
3.7% |
| Angioedema |
3.7% |
| Aortic Valve Stenosis |
3.7% |
| Arthralgia |
3.7% |
| Blister |
3.7% |
| Bone Pain |
3.7% |
| Coeliac Disease |
3.7% |
| Dizziness |
3.7% |
| Drug Level Above Therapeutic |
3.7% |
| Eye Irritation |
3.7% |
| Flatulence |
3.7% |
| Hallucination, Auditory |
3.7% |
| Headache |
3.7% |
|
| Secondary |
| Product Used For Unknown Indication |
36.3% |
| Drug Use For Unknown Indication |
16.0% |
| Chronic Obstructive Pulmonary Disease |
8.2% |
| Osteoporosis |
6.5% |
| Hiv Infection |
4.2% |
| Hypertension |
3.9% |
| Asthma |
2.6% |
| Prophylaxis |
2.6% |
| Abdominal Pain |
2.3% |
| Depression |
2.0% |
| Pain |
2.0% |
| Sedation |
2.0% |
| Atrial Fibrillation |
1.6% |
| Coronary Artery Disease |
1.6% |
| Hypocalcaemia |
1.6% |
| Alcohol Withdrawal Syndrome |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Cardiac Disorder |
1.3% |
| Herpes Zoster |
1.3% |
| Mucous Membrane Disorder |
1.3% |
|
| Melaena |
15.7% |
| Milk-alkali Syndrome |
15.7% |
| Oedematous Pancreatitis |
7.8% |
| Somnolence |
7.8% |
| Renal Failure Acute |
5.9% |
| Diarrhoea |
3.9% |
| Drug Hypersensitivity |
3.9% |
| Dyspnoea |
3.9% |
| Muscle Spasms |
3.9% |
| Pruritus |
3.9% |
| Sepsis |
3.9% |
| Steatorrhoea |
3.9% |
| Tinnitus |
3.9% |
| White Blood Cell Count Decreased |
3.9% |
| Alopecia |
2.0% |
| Aspartate Aminotransferase Increased |
2.0% |
| Blood Pressure Systolic Increased |
2.0% |
| Condition Aggravated |
2.0% |
| Gastroenteritis Viral |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
36.8% |
| Product Used For Unknown Indication |
20.3% |
| Rheumatoid Arthritis |
8.8% |
| Osteoporosis |
5.0% |
| Hypertension |
4.4% |
| Pain |
3.8% |
| Vitamin Supplementation |
3.2% |
| Crohn's Disease |
2.5% |
| Prophylaxis |
2.1% |
| Depression |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Multiple Sclerosis |
1.4% |
| Diabetes Mellitus |
1.3% |
| Mineral Supplementation |
1.1% |
| Hypothyroidism |
1.0% |
| Supplementation Therapy |
1.0% |
| Constipation |
1.0% |
| Vitamin D Deficiency |
0.9% |
| Nausea |
0.9% |
|
| Vomiting |
12.1% |
| Weight Decreased |
9.1% |
| Urinary Tract Infection |
7.0% |
| Pruritus |
6.5% |
| Nausea |
5.4% |
| Pain In Extremity |
5.4% |
| Drug Ineffective |
5.3% |
| Renal Failure Acute |
5.0% |
| Injection Site Pain |
4.8% |
| Rash |
4.3% |
| Pain |
4.2% |
| Pyrexia |
4.2% |
| Flushing |
4.0% |
| Weight Increased |
4.0% |
| Paraesthesia |
3.4% |
| Renal Failure |
3.4% |
| Somnolence |
3.1% |
| Death |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Diarrhoea |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
92.9% |
| Convulsion |
7.1% |
|
| Prescribed Overdose |
75.0% |
| Drug Interaction |
25.0% |
|
